Embedded Files
11/11 2021
Taiwan
Tri-service General Hospital
Dibifree products have been successfully used in HbA1c regulation and evaluation
2022 年 1 月 1 日
東南亞國家聯盟
使用 Virofree® 治療 COVID-19 口服疫苗 EUA 應用
泰國：
目前和泰國政府醫學中心及知名跨國醫療集團合作，積極進行泰國人體臨床前置作業。
馬來西亞：
目前與四個國家組成的回教跨國組織合作，在馬來西亞積極進行人體臨床前置作業，及清真認證的申請，同時也會和全球伊斯蘭聯盟合作，推廣到全球伊斯蘭國家協助COVID-19的防治。
1/1 2022
Association of Southeast Asian Nations
Use Virofree® to treat COVID-19 Oral Vaccine EUA Application
Thailand:
It is presently cooperating with the Thai government medical center and well-known multinational medical groups to carry out clinical pre-operation in Thailand actively.
Malaysia:
Currently cooperating with the Islamic multinational organization composed of four countries to actively carry out human clinical preparatory work in Malaysia and apply for halal certification. At the same time, it will also cooperate with the Global Islamic Alliance to promote to the global Islamic countries to assist in preventing and treating COVID-19..
2022 年 1 月 1 日
中國
擴展 Virofree® & Dibifree® 的 II 期臨床試驗測試
更新中……
1/1 2022
China
Expansion Virofree® & Dibifree® of Phase II clinical trial testing
Updating……
2022 年 1 月 1 日
美國
籌劃美國 IPO
更新中……
1/1 2022
USA
Planning the U.S. IPO
Updating……
Page updated
Google Sites
Report abuse